---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-25-000276"
form_type: "8-K"
ticker: "LIPO"
cik: "0001347242"
company_name: "LIPELLA PHARMACEUTICALS INC."
filed_at: "2025-02-24T23:59:59+00:00"
generated_at: "2026-05-26T05:36:55.091630+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lipella Pharmaceuticals amends placement agent agreement with Spartan Capital Securities

## Summary
- Second Amendment removes at-the-market facility restrictions and modifies tail provision to require 10% fee on investments from accredited retail investors within one year of termination.
- Mirror Offering capacity increased to $7,200,000 (including $1,200,000 over-allotment) with registration statements due within 30 days of closings.
- Variable Rate Transaction restrictions reduced to 90 days post-termination or 10 business days after Registration Statement effective date if $6,000,000 of shares sold.
- Company restricted from disposing securities for 90 days after third closing if all shares under that closing are not registered.

## SEC filing metadata
- accession: 0001753926-25-000276
- form_type: 8-K
- ticker: LIPO
- cik: 0001347242
- company_name: LIPELLA PHARMACEUTICALS INC.
- filed_at: 2025-02-24T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347242/000175392625000276/0001753926-25-000276-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347242/000175392625000276/g084711_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-25-000276
- JSON: https://secwatch.observer/filing/0001753926-25-000276.json
- Plain text: https://secwatch.observer/filing/0001753926-25-000276.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.